This company has been acquired
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Cardiovascular Systems Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Anahtar bilgiler
-54.5%
Kazanç büyüme oranı
-52.3%
EPS büyüme oranı
Medical Equipment Sektör Büyümesi | 8.9% |
Gelir büyüme oranı | 2.1% |
Özkaynak getirisi | -15.8% |
Net Marj | -15.8% |
Son Kazanç Güncellemesi | 31 Dec 2022 |
Yakın geçmiş performans güncellemeleri
Recent updates
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate
Feb 03We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely
Oct 12Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates
Aug 03Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns
Nov 05Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?
Oct 09At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?
Sep 18Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?
Jun 24Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Jun 03We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow
Apr 29Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Mar 17Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain
Feb 10Cardiovascular Systems misses on revenue
Feb 03Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares
Dec 11Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation
Nov 06Gelir ve Gider Dağılımı
Cardiovascular Systems nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
31 Dec 22 | 240 | -38 | 174 | 36 |
30 Sep 22 | 238 | -39 | 173 | 36 |
30 Jun 22 | 236 | -37 | 171 | 37 |
31 Mar 22 | 245 | -33 | 170 | 37 |
31 Dec 21 | 252 | -29 | 169 | 41 |
30 Sep 21 | 257 | -20 | 169 | 42 |
30 Jun 21 | 259 | -13 | 167 | 41 |
31 Mar 21 | 231 | -23 | 157 | 39 |
31 Dec 20 | 228 | -20 | 157 | 36 |
30 Sep 20 | 233 | -24 | 163 | 37 |
30 Jun 20 | 237 | -27 | 170 | 39 |
31 Mar 20 | 262 | -11 | 179 | 41 |
31 Dec 19 | 264 | -7 | 179 | 40 |
30 Sep 19 | 256 | -3 | 173 | 37 |
30 Jun 19 | 248 | 0 | 168 | 32 |
31 Mar 19 | 239 | 2 | 162 | 30 |
31 Dec 18 | 231 | 2 | 158 | 29 |
30 Sep 18 | 224 | 1 | 154 | 28 |
30 Jun 18 | 217 | 2 | 149 | 27 |
31 Mar 18 | 211 | -1 | 145 | 26 |
31 Dec 17 | 207 | -3 | 145 | 24 |
30 Sep 17 | 205 | -2 | 142 | 24 |
30 Jun 17 | 205 | -2 | 144 | 23 |
31 Mar 17 | 199 | -7 | 146 | 23 |
31 Dec 16 | 191 | -28 | 149 | 23 |
30 Sep 16 | 183 | -45 | 157 | 24 |
30 Jun 16 | 177 | -56 | 161 | 26 |
Kaliteli Kazançlar: CSII is currently unprofitable.
Büyüyen Kar Marjı: CSII is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: CSII is unprofitable, and losses have increased over the past 5 years at a rate of 54.5% per year.
Büyüme Hızlandırma: Unable to compare CSII's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: CSII is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-5.5%).
Özkaynak Getirisi
Yüksek ROE: CSII has a negative Return on Equity (-15.82%), as it is currently unprofitable.